Form4.ai tracks every SEC insider trade in real time. See every DFTX insider filing with a free account — no card.
See every DFTX insider filing — free account, no card.
Free accountDefinium Therapeutics, Inc. (DFTX) has 18 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $2.3M. Most recent filing: Sept. 29, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 29, 2026 SEC filing | Karlin Daniel Chief Medical Officer | Sold | $396,894 | — |
| Sep 29, 2026 SEC filing | Barrow Robert Chief Executive Officer | Sold | $1,153,784 | — |
| Sep 29, 2026 SEC filing | Wiley Matthew T. Chief Commercial Officer | Sold | $113,257 | — |
Create a free account to see all 18 DFTX filings from the last 90 days. No card needed.
Create free accountWant DFTX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.